These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15670934)

  • 1. Synthesis and biological evaluation of nucleobase-modified analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd).
    Hrdlicka PJ; Jepsen JS; Nielsen C; Wengel J
    Bioorg Med Chem; 2005 Feb; 13(4):1249-60. PubMed ID: 15670934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of branched and conformationally restricted analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd).
    Hrdlicka PJ; Andersen NK; Jepsen JS; Hansen FG; Haselmann KF; Nielsen C; Wengel J
    Bioorg Med Chem; 2005 Apr; 13(7):2597-621. PubMed ID: 15755661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleosides and nucleotides. 158. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)-cytosine, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity.
    Hattori H; Tanaka M; Fukushima M; Sasaki T; Matsuda A
    J Med Chem; 1996 Dec; 39(25):5005-11. PubMed ID: 8960561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of conformationally restricted and nucleobase-modified analogs of the anticancer compound 3'-C-ethynylcytidine (ECyd).
    Hrdlicka PJ; Jepsen JS; Wengel J
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):397-400. PubMed ID: 16247958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A crucial role of uridine/cytidine kinase 2 in antitumor activity of 3'-ethynyl nucleosides.
    Murata D; Endo Y; Obata T; Sakamoto K; Syouji Y; Kadohira M; Matsuda A; Sasaki T
    Drug Metab Dispos; 2004 Oct; 32(10):1178-82. PubMed ID: 15280220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antitumor effect and mechanism of a novel multifunctional nucleoside, 3'-ethynylnucleoside, on human cancers].
    Tanaka M; Tabata S; Matsuda A; Fukushima M; Eshima K; Sasaki T
    Gan To Kagaku Ryoho; 1997 Feb; 24(4):476-82. PubMed ID: 9063487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic mechanisms of new antitumor nucleoside analogues, 3'-ethynylcytidine (ECyd) and 3'-ethynyluridine (EUrd).
    Kanda H; Takatori S; Matsuda A; Sasaki T; Tanaka M; Fukushima M; Wataya Y
    Nucleic Acids Symp Ser; 1997; (37):137-8. PubMed ID: 9586037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor mechanisms of 3'-ethynyluridine and 3'-ethynylcytidine as RNA synthesis inhibitors: development and characterization of 3'-ethynyluridine-resistant cells.
    Tabata S; Tanaka M; Endo Y; Obata T; Matsuda A; Sasaki T
    Cancer Lett; 1997 Jun; 116(2):225-31. PubMed ID: 9215867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor mechanisms and metabolism of the novel antitumor nucleoside analogues, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil.
    Takatori S; Kanda H; Takenaka K; Wataya Y; Matsuda A; Fukushima M; Shimamoto Y; Tanaka M; Sasaki T
    Cancer Chemother Pharmacol; 1999; 44(2):97-104. PubMed ID: 10412942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro activities of new anticancer duplex drugs linking 2'-deoxy-5-fluorouridine (5-FdU) with 3'-C-ethynylcytidine (ECyd) via a phosphodiester bonding.
    Schott H; Schott S; Schwendener RA
    Bioorg Med Chem; 2009 Oct; 17(19):6824-31. PubMed ID: 19744858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PK-PD modeling of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and the enhanced antitumor effect of its phospholipid derivatives in long-circulating liposomes.
    Takada A; Kamiya H; Shuto S; Matsuda A; Harashima H
    Int J Pharm; 2009 Jul; 377(1-2):52-9. PubMed ID: 19426792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleosides and nucleotides. 175. Structural requirements of the sugar moiety for the antitumor activities of new nucleoside antimetabolites, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and -uracil1.
    Hattori H; Nozawa E; Iino T; Yoshimura Y; Shuto S; Shimamoto Y; Nomura M; Fukushima M; Tanaka M; Sasaki T; Matsuda A
    J Med Chem; 1998 Jul; 41(15):2892-902. PubMed ID: 9667977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer molecular mechanism of 3'-ethynylcytidine (ECyd).
    Wataya Y; Futagami M; Naito T; Uchikubo Y; Yokogawa T; Takenaka K; Kim HS; Matsuda A; Fukushima M; Kitade Y
    Nucleic Acids Res Suppl; 2001; (1):233-4. PubMed ID: 12836350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of two cyclopentenyl-3-deazapyrimidine carbocyclic nucleosides related to cytidine and uridine.
    Copp RR; Marquez VE
    J Med Chem; 1991 Jan; 34(1):208-12. PubMed ID: 1992119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of a new antitumor ribonucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), differs from that of 5-fluorouracil.
    Kazuno H; Shimamoto Y; Tsujimoto H; Fukushima M; Matsuda A; Sasaki T
    Oncol Rep; 2007 Jun; 17(6):1453-60. PubMed ID: 17487404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and properties of 5-pyrrolyl-cytidine and uridine derivatives.
    Miyata K; Mineo R; Tamamushi R; Taguchi H; Seio K; Sekine M
    Nucleic Acids Symp Ser (Oxf); 2004; (48):15-6. PubMed ID: 17150455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituted quinazolines, part 2. Synthesis and in-vitro anticancer evaluation of new 2-substituted mercapto-3H-quinazoline analogs.
    Khalil AA; Abdel-Hamide SG; Al-Obaid AM; El-Subbagh HI
    Arch Pharm (Weinheim); 2003 Apr; 336(2):95-103. PubMed ID: 12761762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 3'-beta-carbamoylmethylcytidine (CAMC) and its derivatives as potential antitumor agents.
    Ichikawa S; Minakawa N; Shuto S; Tanaka M; Sasaki T; Matsuda A
    Org Biomol Chem; 2006 Apr; 4(7):1284-96. PubMed ID: 16557317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total synthesis of hypermodified epothilone analogs with potent in vitro antitumor activity.
    Kuzniewski CN; Gertsch J; Wartmann M; Altmann KH
    Org Lett; 2008 Mar; 10(6):1183-6. PubMed ID: 18303900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleosides and nucleotides. 180. Synthesis and antitumor activity of nucleosides that have a hydroxylamino group instead of a hydroxyl group at the 2'- or 3'-position of the sugar moiety.
    Ogawa A; Tanaka M; Sasaki T; Matsuda A
    J Med Chem; 1998 Dec; 41(25):5094-107. PubMed ID: 9836625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.